173 related articles for article (PubMed ID: 19696007)
1. [Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
Koffi KG; Nanho DC; Tolo A; N'Dathz E; Kouakou B; Meite N; Ayemou R; Sanogo I
Bull Cancer; 2009 Sep; 96(9):901-6. PubMed ID: 19696007
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
Koffi G; Kouakou B; Ndiaye FS; Ndathz E; Sanogo I; Sangare A
Bull Cancer; 2007 Oct; 94(10):902-6. PubMed ID: 17964984
[TBL] [Abstract][Full Text] [Related]
3. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
[TBL] [Abstract][Full Text] [Related]
4. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Antich Rojas J; Balaguer H; Cladera A
Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
[No Abstract] [Full Text] [Related]
5. [Chronic lymphoid leukemia in the Ivory Coast. (69 cases)].
Toutoukpo Y; Tea N; Rain JD
Med Trop (Mars); 1991; 51(4):417-20. PubMed ID: 1666168
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).
Robak T; Błoński JZ; Kasznicki M; Góra-Tybor J; Dmoszyńska A; Wojtaszko M; Skotnicki AB; Nowak W; Hellmann A; Lewandowski K; Zdziarska B; Konopka L; Ceglarek B; Dwilewicz-Trojaczek J; Boguradzki P; Kuliczkowski K; Sułek K; Warzocha K
Med Sci Monit; 2005 Oct; 11(10):PI71-9. PubMed ID: 16192912
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic, clinical and therapeutic aspects of chronic lymphoid leukemia: apropos of 120 cases].
Khalifa M; Chehata S; Laatiri MA; Grira C; Gharbi O; Kortas M; Khelif A; Ennabli S
Tunis Med; 2002 Oct; 80(10):584-9. PubMed ID: 12632751
[TBL] [Abstract][Full Text] [Related]
8. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
[TBL] [Abstract][Full Text] [Related]
9. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
Binet JL
Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
[No Abstract] [Full Text] [Related]
10. A single unit lymphoma experience: outcome in a Cape Town academic centre.
Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
[TBL] [Abstract][Full Text] [Related]
14. The experience of the French Cooperative Group in the treatment of CLL.
Travade P
Nouv Rev Fr Hematol (1978); 1990; 32(5):313-7. PubMed ID: 2099402
[TBL] [Abstract][Full Text] [Related]
15. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.
Arcaini L; Paulli M; Burcheri S; Rossi A; Spina M; Passamonti F; Lucioni M; Motta T; Canzonieri V; Montanari M; Bonoldi E; Gallamini A; Uziel L; Crugnola M; Ramponi A; Montanari F; Pascutto C; Morra E; Lazzarino M;
Br J Haematol; 2007 Jan; 136(2):301-4. PubMed ID: 17233821
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic pleural effusion as a complication of chronic lymphocytic leukemia.
Zeidman A; Yarmolovsky A; Djaldetti M; Mittelman M
Haematologia (Budap); 1995; 26(3):173-5. PubMed ID: 7797147
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
Ayyildiz O; Isikdogan A; Bolaman Z; Muftuoglu E
Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
[No Abstract] [Full Text] [Related]
18. Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion: report from the Polish Adult Leukemia Group.
Robak T; Blonski JZ; Wawrzyniak E; Gora-Tybor J; Palacz A; Dmoszynska A; Konopka L; Warzocha K; Jamroziak K
Cancer; 2009 Jan; 115(1):94-100. PubMed ID: 19025975
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival among patients with chronic lymphocytic leukemia (CLL) treated in Department of Hematology, Medical University of Lublin.
Sokołowska B; Wasik E; Kniaź M; Brzozowska J; Podhorecka M; Sledzińska M; Domański D
Ann Univ Mariae Curie Sklodowska Med; 2000; 55():103-9. PubMed ID: 11482058
[No Abstract] [Full Text] [Related]
20. [Vincristine-induced recurrent laryngeal nerve paralysis].
Núñez E; Solano D; Arreita A; Franco-Vicario R; Miguel F
Rev Clin Esp; 1992 Mar; 190(4):214-5. PubMed ID: 1589626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
